Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study of DM002 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Ovarian NeoplasmsProstatic NeoplasmsEndometrial NeoplasmsColorectal NeoplasmsSolid Carcinoma
- Interventions
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
- Target Recruit Count
- 160
- Registration Number
- NCT06751329
- Locations
- 🇺🇸
The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States
🇦🇺Cancer Care Wollongong, Wollongong, New South Wales, Australia
A Study of DM001 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Carcinoma, Non-Small-Cell LungBreast NeoplasmsSolid Carcinoma
- Interventions
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
- Target Recruit Count
- 128
- Registration Number
- NCT06475937
- Locations
- 🇺🇸
Sarah Cannon Research Institute (SCRI), Nashville, Tennessee, United States
🇺🇸University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇦🇺Icon Cancer Centre South Brisbane, South Brisbane, Queensland, Australia
News
No news found